EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:94614 - 2-[4-[3-(11-benzo[b][1]benzazepinyl)propyl]-1-piperazinyl]ethanol
| Formula | C23H29N3O |
| Net Charge | 0 |
| Average Mass | 363.505 |
| Monoisotopic Mass | 363.23106 |
| SMILES | OCCN1CCN(CCCN2c3ccccc3C=Cc3ccccc32)CC1 |
| InChI | InChI=1S/C23H29N3O/c27-19-18-25-16-14-24(15-17-25)12-5-13-26-22-8-3-1-6-20(22)10-11-21-7-2-4-9-23(21)26/h1-4,6-11,27H,5,12-19H2 |
| InChIKey | YNZFUWZUGRBMHL-UHFFFAOYSA-N |
| Roles Classification |
|---|
| Applications: | antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. anxiolytic drug Anxiolytic drugs are agents that alleviate anxiety, tension, and anxiety disorders, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. antipsychotic agent Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| 2-[4-[3-(11-benzo[b][1]benzazepinyl)propyl]-1-piperazinyl]ethanol (CHEBI:94614) has role antidepressant (CHEBI:35469) |
| 2-[4-[3-(11-benzo[b][1]benzazepinyl)propyl]-1-piperazinyl]ethanol (CHEBI:94614) has role antipsychotic agent (CHEBI:35476) |
| 2-[4-[3-(11-benzo[b][1]benzazepinyl)propyl]-1-piperazinyl]ethanol (CHEBI:94614) has role anxiolytic drug (CHEBI:35474) |
| 2-[4-[3-(11-benzo[b][1]benzazepinyl)propyl]-1-piperazinyl]ethanol (CHEBI:94614) is a dibenzoazepine (CHEBI:47804) |
| 2-[4-[3-(11-benzo[b][1]benzazepinyl)propyl]-1-piperazinyl]ethanol (CHEBI:94614) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| NSC-169867 | ChEMBL |
| opipramol | ChEMBL |
| opipramol dihydrochloride | DrugCentral |
| Opipramol dura | ChEMBL |
| opramidol | DrugCentral |
| Citations |
|---|